Literature DB >> 23839357

Guidelines for the management of acute cervical spine and spinal cord injuries: 2013 update.

Beverly C Walters, Mark N Hadley, R John Hurlbert, Bizhan Aarabi, Sanjay S Dhall, Daniel E Gelb, Mark R Harrigan, Curtis J Rozelle, Timothy C Ryken, Nicholas Theodore.   

Abstract

Entities:  

Mesh：

Year:  2013        PMID： 23839357     DOI： 10.1227/01.neu.0000430319.32247.7f

Source DB:  PubMed          Journal:  Neurosurgery        ISSN： 0148-396X            Impact factor:   4.654


× No keyword cloud information.
  104 in total

1.  Cochrane in CORR1: Steroids for Acute Spinal Cord Injury (Review).

Authors:  Nathan Evaniew; Marcel Dvorak
Journal:  Clin Orthop Relat Res       Date:  2016-01       Impact factor: 4.176

2.  [Development and first application testing of a new protocol for preclinical spinal immobilization in children : Assessment of indications based on the E.M.S. IMMO Protocol Pediatric].

Authors:  Philip C Nolte; Davut D Uzun; Shiyao Liao; Matthias Kuch; Paul A Grützner; Matthias Münzberg; Michael Kreinest
Journal:  Unfallchirurg       Date:  2020-04       Impact factor: 1.000

3.  Cervical spinal clearance: A prospective Western Trauma Association Multi-institutional Trial.

Authors:  Kenji Inaba; Saskya Byerly; Lisa D Bush; Matthew J Martin; David T Martin; Kimberly A Peck; Galinos Barmparas; Matthew J Bradley; Joshua P Hazelton; Raul Coimbra; Asad J Choudhry; Carlos V R Brown; Chad G Ball; Jill R Cherry-Bukowiec; Clay Cothren Burlew; Bellal Joseph; Julie Dunn; Christian T Minshall; Matthew M Carrick; Gina M Berg; Demetrios Demetriades
Journal:  J Trauma Acute Care Surg       Date:  2016-12       Impact factor: 3.313

4.  Optimization of the mean arterial pressure and timing of surgical decompression in traumatic spinal cord injury: a retrospective study.

Authors:  A Dakson; D Brandman; G Thibault-Halman; S D Christie
Journal:  Spinal Cord       Date:  2017-06-20       Impact factor: 2.772

5.  CCL-2 as a possible early marker for remission after traumatic spinal cord injury.

Authors:  R A Heller; T F Raven; T Swing; K Kunzmann; V Daniel; P Haubruck; M Akbar; P A Grützner; G Schmidmaier; B Biglari; A Moghaddam
Journal:  Spinal Cord       Date:  2017-06-20       Impact factor: 2.772

6.  Mean Arterial Blood Pressure Correlates with Neurological Recovery after Human Spinal Cord Injury: Analysis of High Frequency Physiologic Data.

Authors:  Gregory Hawryluk; William Whetstone; Rajiv Saigal; Adam Ferguson; Jason Talbott; Jacqueline Bresnahan; Sanjay Dhall; Jonathan Pan; Michael Beattie; Geoffrey Manley
Journal:  J Neurotrauma       Date:  2015-08-17       Impact factor: 5.269

Review 7.  A review of spinal cord perfusion pressure guided interventions in traumatic spinal cord injury.

Authors:  Mathias Møller Thygesen; Tim Damgaard Nielsen; Mads Rasmussen; Dariusz Orlowski; Michael Pedersen; Mikkel Mylius Rasmussen
Journal:  Eur Spine J       Date:  2021-06-25       Impact factor: 3.134

8.  Reporting of CT cervical spine after office hours by radiology trainees-analysis of discrepancy rates and RADPEER scores.

Authors:  Yet Yen Yan; Jenn Nee Khoo; Tien Jin Tan; Joe Francis; Le Roy Chong; Elizabeth Hui-Ying Chan
Journal:  Emerg Radiol       Date:  2018-03-14

9.  Higher Mean Arterial Pressure Values Correlate with Neurologic Improvement in Patients with Initially Complete Spinal Cord Injuries.

Authors:  Joshua Stephen Catapano; Gregory William John Hawryluk; William Whetstone; Rajiv Saigal; Adam Ferguson; Jason Talbott; Jacqueline Bresnahan; Sanjay Dhall; Jonathan Pan; Michael Beattie; Geoffrey Manley
Journal:  World Neurosurg       Date:  2016-08-23       Impact factor: 2.104

10.  Pharmacological Stimulation of Mitochondrial Biogenesis Using the Food and Drug Administration-Approved β2-Adrenoreceptor Agonist Formoterol for the Treatment of Spinal Cord Injury.

Authors:  Natalie E Scholpa; Hannah Williams; Wenxue Wang; Daniel Corum; Aarti Narang; Stephen Tomlinson; Patrick G Sullivan; Alexander G Rabchevsky; Rick G Schnellmann
Journal:  J Neurotrauma       Date:  2018-11-16       Impact factor: 5.269
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.